DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway - Quiz - MDSpire

DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway

  • By

  • Anrui Li

  • Jing-wen Xu

  • Jian-hua Qin

  • Qi Yuan

  • Lichen Teng

  • May 22, 2026

  • 0 min

Share

Original Source(s)

DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway

  • by Anrui Li, Jing-wen Xu, Jian-hua Qin, Qi Yuan, Lichen Teng

  • May 22, 2026

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma